Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Apr 19, 2025; 15(4): 103362
Published online Apr 19, 2025. doi: 10.5498/wjp.v15.i4.103362
Table 2 Demographic and clinical features of the sample

Total sample (n = 52)
IRT (n = 26)
IRT + MBI (n = 26)
Statistics
Age, years39.71 ± 8.9840.15 ± 9.3839.42 ± 6.33t = 0.292, P = 0.771
Sex
    Male41 (78.8)21 (80.8)20 (76.9)χ2 = 0.115, P = 0.734
    Female11 (21.2)5 (19.2)6 (23.1)
Years since diagnosis14.13 ± 7.6614.58 ± 8.2213.69 ± 7.20t = 0.413, P = 0.682
Education years12.04 ± 2.0811.93 ± 1.8912.15 ± 2.25t = -0.399, P = 0.691
Diagnosis
    Paranoid schizophrenia23 (44.2)11 (42.3)12 (43.2)χ2 = 0.134, P = 0.999
    Undifferentiated schizophrenia8 (15.4)4 (15.4)8 (15.4)
    Disorganized schizophrenia4 (7.7)2 (7.7)2 (7.7)
    Schizoaffective disorder11 (21.2)6 (23.1)5 (19.2)
    Bipolar disorder4 (7.7)2 (7.7)2 (7.7)
    Delusional disorder2 (3.8)1 (3.8)1 (3.8)
PANSS
    Positive14.90 ± 5.8014.69 ± 5.2515.11 ± 6.40t = -0.261, P = 0.796
    Negative19.08 ± 4.0119.16 ± 4.0119.00 ± 4.09t = 0.137, P = 0.892
    General36.11 ± 8.6136.50 ± 9.6335.74 ± 7.64t = 0.319, P = 0.751
    Total70.23 ± 15.4670.85 ± 15.2069.61 ± 15.90t = 0.284, P = 0.777